These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 25564615

  • 1. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M, Leysath CE, Tremblay JM, Vrentas C, Crown D, Leppla SH, Shoemaker CB.
    J Biol Chem; 2015 Mar 06; 290(10):6584-95. PubMed ID: 25564615
    [Abstract] [Full Text] [Related]

  • 2. Adenoviral Expression of a Bispecific VHH-Based Neutralizing Agent That Targets Protective Antigen Provides Prophylactic Protection from Anthrax in Mice.
    Moayeri M, Tremblay JM, Debatis M, Dmitriev IP, Kashentseva EA, Yeh AJ, Cheung GY, Curiel DT, Leppla S, Shoemaker CB.
    Clin Vaccine Immunol; 2016 Jan 06; 23(3):213-8. PubMed ID: 26740390
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F, Lévy M, Landier A, Lafaye P, Mock M.
    Infect Immun; 2004 Nov 06; 72(11):6313-7. PubMed ID: 15501759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H.
    Antimicrob Agents Chemother; 2016 Aug 06; 60(8):4878-85. PubMed ID: 27270276
    [Abstract] [Full Text] [Related]

  • 8. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.
    Infect Immun; 2007 Nov 06; 75(11):5425-33. PubMed ID: 17646360
    [Abstract] [Full Text] [Related]

  • 9. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R, Ribot WJ, Abshire TG, Jett M, Ezzell J.
    BMC Infect Dis; 2008 Sep 22; 8():124. PubMed ID: 18808698
    [Abstract] [Full Text] [Related]

  • 10. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    Dumas EK, Demiraslan H, Ingram RJ, Sparks RM, Muns E, Zamora A, Larabee J, Garman L, Ballard JD, Boons GJ, James JA, Kayabas U, Doganay M, Farris AD.
    PLoS One; 2020 Sep 22; 15(4):e0230782. PubMed ID: 32294093
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
    Mechaly A, Levy H, Epstein E, Rosenfeld R, Marcus H, Ben-Arie E, Shafferman A, Ordentlich A, Mazor O.
    J Biol Chem; 2012 Sep 21; 287(39):32665-73. PubMed ID: 22869370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Generation and screening of efficient neutralizing single domain antibodies (VHHs) against the critical functional domain of anthrax protective antigen (PA).
    Shali A, Hasannia S, Gashtasbi F, Abdous M, Shahangian SS, Jalili S.
    Int J Biol Macromol; 2018 Jul 15; 114():1267-1278. PubMed ID: 29524493
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detoxified lethal toxin as a potential mucosal vaccine against anthrax.
    Xu Q, Zeng M.
    Clin Vaccine Immunol; 2008 Apr 15; 15(4):612-6. PubMed ID: 18256208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.